Lumenis Demonstrates Industry Leadership with Comprehensive Ophthalmic Laser Line at 2006 AAO

Announces Record Registration for Educational Symposia: ‘Lumenis Multicolor Laser Symposium’ and ‘Managing Glaucoma: a Full Spectrum Approach’

November 10, 2006 - Yokneam, Israel

Lumenis^® Ltd., a global developer, manufacturer and seller of laser, light- and radiofrequency-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications, announced today the introduction of Aura™ PT, a new Nd:YAG laser – adding to its industry-leading comprehensive ophthalmic line. Lumenis also announced that at the 2006 American Academy of Ophthalmology Annual Meeting, which is scheduled November 11-14 in Las Vegas, Nevada (USA), the company is hosting two major clinical symposia: ‘Lumenis Multicolor Laser Symposium’ and ‘Managing Glaucoma: a Full-Spectrum Approach’.

Avner Raz, Lumenis President and CEO, commented, “At this year’s AAO, we are pleased to showcase the breadth of our ophthalmic laser line that today provides clinical solutions from the physician’s office to the OR (Operating Room) – and proudly introduce the newest member, the Aura PT. Listening to our customers, our new Aura offers physicians a photodisruptor that is easy to use, exceptionally robust and affordably priced with a small footprint. Our comprehensive line of ophthalmic lasers provides physicians a complete set of treatment solutions for glaucoma, secondary cataracts and retina conditions – Lumenis truly offers it all!”

“In addition, we are hosting, with record pre-registration, two medical education events for ophthalmologists. The high level of pre-registrants underscores the strong interest in our products – and the clinical solutions they offer – by ophthalmologists worldwide,” continued Avner Raz.

Lumenis ‘Solutions’ Presented In-Booth at the AAO in Las Vegas – Booth #3431

New this year, the Aura™ PT, is the culmination of many years of Nd:YAG laser photodisruptor manufacture and design. This system has a small footprint, is easy to use yet exceptionally robust – and is affordably priced!

Selecta® Family of Lasers is a bold new concept of laser ownership, offering a modular and upgradable platform for full choice of therapy and maximum treatment flexibility.

• Selecta® 1064 – offers the physician an Nd:YAG to treat the anterior segment of the eye for posterior capsular haze and peripheral iridotomy, with multiple upgrade options that are simple and straightforward.
• Selecta® Duo – results from adding Lumenis’ S-Link LaserLink™ to the 1064, offering a versatile Nd:YAG and 532 nm Photocoagulator combination laser.
• Selecta® Duet™ – is created by combining a Q-switched frequency-doubled 532 nm SLT laser with the Selecta 1064, expanding treatment options to include Selective Laser Trabeculoplasty (SLT) for open-angle glaucoma.
• Selecta® Trio – is the ultimate all-in-one system, offering maximum flexibility in choice of therapy by combining the Nd:YAG platform with a diode-pumped solid-state (DPSS) 532 Photocoagulator and a Q-switched frequency-doubled 532nm (SLT) laser.

Novus® 3000 is designed to be a complete solution for the Operating Room, a fully-integrated and powerful 532 nm OR Photocoagulator with reliable DPSS technology. The Novus 3000 provides simplified operation using a touchscreen interface with remote control and comes standard with dual-port delivery, two independent illumination sources (LIO & Probe), built-in storage for a laser indirect ophthalmoscope (LIO), remote control, foot switch and other accessories.

Novus® Varia™ continues to be the industry’s most sophisticated Multicolor Diode-Pumped, Solid-State (DPSS) photocoagulator. Varia has proven to be a true ‘time saving’ instrument for the busy retina specialist. Demanding clinical situations and treatment decisions require a laser with an intuitive and easy-to-use interface. The Varia is an extension of the surgeon’s professional know-how and maximizes patient throughput.

In-Booth Presentations – Several physician speakers are scheduled on Saturday, November 11th and Sunday, November 12th in Lumenis’ Booth #3431 at the AAO. They will address: ‘Clinical Advantages of Multiwavelength’, ‘Advanced Treatment Protocols for SLT’ (selective laser trabeculoplasty), and ‘The Latest on SRT’ (selective retina therapy) which is in development and for which Lumenis holds exclusive worldwide licensing rights.

About Lumenis

Lumenis is a global developer, manufacturer and seller of laser, light- and radiofrequency-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications. The Company offers a wide range of products along with extensive product support systems including training, education and service. Lumenis invests heavily in research and development to maintain and enhance its leading industry position. The Company holds numerous patents worldwide on its technologies. For more information about Lumenis and its products, log onto: http://www.lumenis.com

Investors:

Lauri Hanover

1-866-232-6803
972-4-959-9122

 

Search

| Advanced Search| Site Map| Home